PAPER Mateos MJ, Strozzi AG, Barrios FA, Bribiesca E, Alcauter S, Flores JM
PAPER Soloveva MV, Jamadar SD, Velakoulis D, Poudel G, Georgiou-Karistianis N31734228
PAPER Henderson MX, Sengupta M, Trojanowski JQ, Lee VM31733655
PAPER Forester BP, Rahman AT, Harper DG, Petrides G31734085
PAPER Zhang J, Park ES, Park HJ, Yan R, Grudniewska M, Zhang X, Oh S, Yang X, Baum J, Mouradian MM
Apoptosis signal regulating kinase 1 deletion mitigates α-synuclein pre-formed fibril propagation in mice.Neurobiol Aging. 2019 Sep 25;85:49-57. PubMed: 31734439
PAPER Hassan R, Rabea AA, Ragae A, Sabry D
The prospective role of mesenchymal stem cells exosomes on circumvallate taste buds in induced Alzheimer's disease of ovariectomized albino rats: (Light and transmission electron microscopic study).Arch Oral Biol. 2019 Oct 31;110:104596. PubMed: 31734542
PAPER Xiao B, He N, Wang Q, Cheng Z, Jiao Y, Haacke EM, Yan F, Shi F
Quantitative susceptibility mapping based hybrid feature extraction for diagnosis of Parkinson's disease.Neuroimage Clin. 2019 Nov 5;24:102070. PubMed: 31734535
PAPER Canas LS, Sudre CH, De Vita E, Nihat A, Mok TH, Slattery CF, Paterson RW, Foulkes AJ, Hyare H, Cardoso MJ, Thornton J, Schott JM, Barkhof F, Collinge J, Ourselin S, Mead S, Modat M
Prion disease diagnosis using subject-specific imaging biomarkers within a multi-kernel Gaussian process.Neuroimage Clin. 2019 Oct 25;24:102051. PubMed: 31734530
PAPER Hassani OK, Rymar VV, Nguyen KQ, Huo L, Cloutier JF, Miller FD, Sadikot AF
The noradrenergic system is necessary for survival of vulnerable midbrain dopaminergic neurons: implications for development and Parkinson's disease.Neurobiol Aging. 2019 Sep 30;85:22-37. PubMed: 31734438
JOB 2019-11-18 Employer Rosalind Franklin University / The Chicago Medical School Principal Investigator Grace Stutzmann Contact firstname.lastname@example.org Description The Center for Neurodegenerative Disease and Therapeutics at the Rosalind Franklin ...
Blade Therapeutics, IncSouth San Francisco, United States
COMMENT This is an extraordinary study that provides a final piece of evidence for the causal involvement of microglia in Alzheimer’s disease. This work follows up a previous report from the same group, where the authors performed transcriptomic analysis of human ...
AstellasCambridge, United States
COMMENT The intriguing and encouraging results of the GV971 trial could be explained by an alternative—or perhaps additional—mechanism: the protective effect against AD might well be the consequence of the drug acting as an antiviral agent against HSV1, which has ...